comscore Cardax plans 200-for-1 reverse stock split | Honolulu Star-Advertiser
Hawaii News

Cardax plans 200-for-1 reverse stock split

Honolulu-based biopharmaceutical company Cardax Inc., which produces the anti-inflammatory product ZanthoSyn, declared Tuesday a 200-for-1 reverse stock split that will be effective today. Read more

Scroll Up